Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 3
2013 6
2014 1
2015 1
2016 2
2017 4
2018 2
2019 4
2020 5
2021 9
2022 7
2023 5
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
B7-H3: An Attractive Target for Antibody-based Immunotherapy.
Kontos F, Michelakos T, Kurokawa T, Sadagopan A, Schwab JH, Ferrone CR, Ferrone S. Kontos F, et al. Among authors: michelakos t. Clin Cancer Res. 2021 Mar 1;27(5):1227-1235. doi: 10.1158/1078-0432.CCR-20-2584. Epub 2020 Oct 13. Clin Cancer Res. 2021. PMID: 33051306 Free PMC article. Review.
Recurring Pancreatic Neuroendocrine Tumor: Timing and Pattern of Recurrence and Current Treatment.
Pulvirenti A, Javed AA, Michelakos T, Sekigami Y, Zheng J, Kalvin HL, McIntyre CA, Nebbia M, Chou JF, Gonen M, Raj N, Reidy-Lagunes DL, Zureikat AH, Ferrone CR, He J, Wei AC; PAncreatic Neuroendocrine Disease Alliance (PANDA). Pulvirenti A, et al. Among authors: michelakos t. Ann Surg. 2023 Nov 1;278(5):e1063-e1067. doi: 10.1097/SLA.0000000000005809. Epub 2023 Jan 24. Ann Surg. 2023. PMID: 37796750 Free PMC article.
Interplay between B7-H3 and HLA class I in the clinical course of pancreatic ductal adenocarcinoma.
Cattaneo G, Ventin M, Arya S, Kontos F, Michelakos T, Sekigami Y, Cai L, Villani V, Sabbatino F, Chen F, Sadagopan A, Deshpande V, Moore PA, Ting DT, Bardeesy N, Wang X, Ferrone S, Ferrone CR. Cattaneo G, et al. Among authors: michelakos t. Cancer Lett. 2024 Apr 10;587:216713. doi: 10.1016/j.canlet.2024.216713. Epub 2024 Feb 14. Cancer Lett. 2024. PMID: 38364961
B7-H3 targeted antibody-based immunotherapy of malignant diseases.
Michelakos T, Kontos F, Barakat O, Maggs L, Schwab JH, Ferrone CR, Ferrone S. Michelakos T, et al. Expert Opin Biol Ther. 2021 May;21(5):587-602. doi: 10.1080/14712598.2021.1862791. Epub 2020 Dec 21. Expert Opin Biol Ther. 2021. PMID: 33301369 Free PMC article.
Prediction of R Status in Resections for Pancreatic Cancer Using Simplified Radiological Criteria.
Bolm L, Pisuchpen N, Qadan M, Kambadakone A, Sondermann S, Mueller K, Petruch N, May K, Zelga P, Nebbia M, Michelakos T, Baba T, Roldan J, Harrison JM, Honselmann KC, Keck T, Lillemoe KD, Ferrone CR, Wellner UF, Fernandez-Del Castillo C. Bolm L, et al. Among authors: michelakos t. Ann Surg. 2022 Aug 1;276(2):215-221. doi: 10.1097/SLA.0000000000005433. Epub 2022 Mar 9. Ann Surg. 2022. PMID: 36036988
Defective HLA class I antigen processing machinery in cancer.
Cai L, Michelakos T, Yamada T, Fan S, Wang X, Schwab JH, Ferrone CR, Ferrone S. Cai L, et al. Among authors: michelakos t. Cancer Immunol Immunother. 2018 Jun;67(6):999-1009. doi: 10.1007/s00262-018-2131-2. Epub 2018 Feb 27. Cancer Immunol Immunother. 2018. PMID: 29487978 Free PMC article.
40 results